NovoCure Ltd (NASDAQ: NVCR) stock enjoyed a major increase of 12.2% on 7/30/24. The shares closed at $23.34. Moreover, trading volume in this advance was unusually high at 191% of normal. The stock has risen 23.6% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, NVCR is expected to continue to be Value Creation neutral.
NovoCure has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. NovoCure has a very low Appreciation Score of 8 but a very high Power Rating of 86, and the Low Neutral Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment